Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Industry Insights Seminar Series is hosted by the Business Partnerships Office and sponsored by the BioEscalator.

  • First Tuesday of every month
  • 12.00 -1.00 pm 
  • In person and via Zoom
  • Networking & 1:1 meeting opportunities

Selected industry speakers provide seminars that are scientific in nature, across a range of medical or health topics.  Speakers are encouraged to bring along colleagues providing the opportunity for Oxford scientists to attend a scientific seminar of interest and also to network with industry scientists. One to one meetings can be facilitated upon request.  Seminars are suitable for all scientists with some knowledge or interest in each topic area, from PhD students to PIs.  Although mostly aimed at an academic audience, those located in the BioEscalator and Wood Centre, as well as local spinouts, are welcome to attend. 

 17 May 2022: Physical Modelling and Machine Intelligence for Accelerated Discovery

Company: IBM

Presenter: Jason Crain, IBM Research 

IBM Research, are inventing what's next in AI, quantum computing, and hybrid cloud to shape the world ahead.  

They’re discovering the new materials that will become the next generation of computer chips; They’re building bias-free AI that can take the burden out of healthcare decisions; They’re designing a hybrid-cloud platform that essentially operates as the world’s computer. They’re moving quantum computing from a theoretical concept to machines that are redefining industry and society.

Register for the IBM talk

14 June 2022

Company: Psious

Presenter: Iris-Valerie Stracke (Head of Clinical and Regulatory Affairs)

Psious' virtual reality tool can be used by mental health professionals in CBTexposure therapy and other interventions allowing them to have full control over the parameters.

Through close collaboration with leading public and private institutions, Psious are proud to advance research and promote evidence-based care for better mental-health, globally.

Register for the Psious talk

 6 September 2022

Company: Natural Cycles

Presenter:  Jack Pearson (Medical Affairs Manager)

Natural Cycles is an app powered by an algorithm that determines fertility status based on basal body temperature. Measure with the NC° thermometer, enter into the app, and let the algorithm do the work.

Register for the Natural Cycles talk

Changes to the event format

These events were in person at the BioEscalator, however, since Covid-19, these seminars have become a hybrid event of in person and virtual.


Please contact either Sheena Lee if you have any questions.

If you have an industry partner you would like to invite to speak, please contact Sheena Lee.

Previous Talks


Company: Oxford Biomedica

Presenter: Yatish Lad (Vice President, Head of Early Development)


1 March 2022: Combining Robotics and AI: The Emergence of Data-Driven Drug Discovery

Company: Arctoris

Presenter: Martin-Immanuel Bittner (Co-founder and CEO)


1 February 2022: Bridgebio Pharma: Turning Translational Academic Research into Medicines for Patients with Genetic Diseases

Company BridgeBio

Presenter:  Anna Hakes, PhD


7 December 2021: Target discovery opportunities using machine learning on longitudinal patient journeys

Company: Novo Nordisk Research Centre Oxford 

Presenter: Ramneek Gupta-Head of Computational Biology


2nd November 2021: Translational Fellowships: Perspectives from a BMS mentor and 5 Oxford-BMS Fellows 

Company: Bristol Myers Squibb

Presenter: Professor Anjan Thakurta


5th October 2021: Humanising drugs

Company: Vertex

Presenter: David Price


7th September: Development of Novel Medicines Using High Resolution, Native Mass Spectrometry of Intact Protein Assemblies

Company: OMass

Presenter: Katharina Duerr


July 2021: Tumour Re-Engineering

Company: PsiOxus

Presenter: Manuela Zonca - Senior Research Scientist PsiOxus


4th May 2021: Improving Drug Delivery in Ophthalmology

Company: Visusnano

Presenter: Joanna Gould - CEO, VisusNano



6th April 2021: Accelerating Covid-19 Antibody Discovery through Industry-Academia Consortium

Company:  BioIndustry Association (BIA)

Presenter:  Jane Osbourn OBE, CSO Alchemab and Paul Kellam VP infectious diseases and vaccines, Kymab.


2nd March 2021:  Transforming the Path for Equitable Access to Rapid Diagnostics for Epidemics

Company: Mologic

Presenter:  Joe Fitchett - Medical Director


2 February 2021: Targeting the Aryl Hyrdrocarbon Receptor (AHR) as a Novel Immunotherapy for the Treatment of Cancer

Company: Bayer AG

Presenter: Dr Ilona Gutcher - Group Leader Oncology


5 January 2021: Exosome-Based Therapies for the Treatment of Rare Genetic Diseases

Company: Evox Therapeutics 

Presenter: David Lowe - Vice President, Research


6 October 2020: Maintaining Human Livers Outside Of The Body: From Advances In Transplant Medicine To Developing Liver Nash Therapies

Company: Ochre Bio & OrganOx

Presenters: Quin Wills & Jack O'Meara, CSO and CEO Ochre Bio and Andy Self, Commercial Director at OrganOx


1 September 2020: Biotherapeutic Medicines From Botulinum Neurotoxins

Company: Ipsen

Presenter: Matthew Beard


7 July 2020: Translational Science & Medicine In Industry

Company: Janssen R&D

Presenter: Luke Devey, VP Translational science


2 June 2020: A Multi-Omics Approach For Type 2 Diabetes Target Discovery: Identification And Characterisation Of Disease-Specific Small Open Reading Frame Encoded Peptides

Company: Novo Nordisk

Presenter: Dr. Bill Haynes, Site Head and Vice President, Novo Nordisk Research Centre Oxford


3 March 2020: Deep Learning Based Image Enhancement In Positron Emission Tomography

Company: GE Healthcare

Presenter: Dr Abolfazl Mehranian - Imaging Scientist 


4 February 2020: What Disease? – Do We Have The Right Approach To Disease Classification And How This Should Impact Our Approach To Treatment

Company: Sensyne Health 

Presenter: Dr Rabia Khan - Chief of Translational Medicine 


7 January 2020: Utility Of Non-Invasive Image Derived Biomarkers To Characterise Health And Disease: Advances Towards Personalised Medicine

Company: Perspectum Diagnostics Ltd

Presenter: Dr Andrea Dennis - Head of Biomarker Sciences


4 December 2019: When Less Is More - A New Twist To GalNAc-Conjugated siRNA For Treatment Of Liver-Related Disorders

Company: Silence Therapeutics

Presenter: Dr Marie Wikstrom Lindholm - VP Head of Technology Innovation 

On this page